Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Board granted a 10 percent evaluation for the veteran's service-connected basal cell carcinomas of the face and neck, but denied a compensable rating for his scar below the right eye as a residual of an excision of a basal cell carcinoma.

The deciding factor: The VA examinations and clinical records showed that the veteran had multiple basal cell carcinomas on his face and neck, warranting a 10 percent evaluation under DC 7819. The scar was rated noncompensable as it did not meet the criteria for a compensable rating.

Claimed conditions
Basal cell carcinomas of the face and neck
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
10%
Decision date
May 23, 2002
Citation
0204931

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0204931.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.